Moderna, Inc. (MRNA)

Moderna Statistics

Total Valuation

Moderna has a market cap or net worth of $15.16 billion. The enterprise value is $7.31 billion.

Market Cap	15.16B
Enterprise Value	7.31B

Important Dates

The next estimated earnings date is Thursday, February 20, 2025, before market open.

Earnings Date	Feb 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Moderna has 384.82 million shares outstanding. The number of shares has decreased by -0.20% in one year.

Current Share Class	384.82M
Shares Outstanding	384.82M
Shares Change (YoY)	-0.20%
Shares Change (QoQ)	+3.91%
Owned by Insiders (%)	9.59%
Owned by Institutions (%)	68.60%
Float	347.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.97
Forward PS	5.17
PB Ratio	1.27
P/TBV Ratio	1.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.44
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.39, with a Debt / Equity ratio of 0.11.

Current Ratio	4.39
Quick Ratio	3.95
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-112.21

Financial Efficiency

Return on equity (ROE) is -17.52% and return on invested capital (ROIC) is -11.94%.

Return on Equity (ROE)	-17.52%
Return on Assets (ROA)	-9.55%
Return on Capital (ROIC)	-11.94%
Revenue Per Employee	$907,321
Profits Per Employee	-$397,143
Employee Count	5,600
Asset Turnover	0.29
Inventory Turnover	13.50

Taxes

Income Tax	-129.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.79% in the last 52 weeks. The beta is 1.59, so Moderna's price volatility has been higher than the market average.

Beta (5Y)	1.59
52-Week Price Change	-55.79%
50-Day Moving Average	46.73
200-Day Moving Average	91.31
Relative Strength Index (RSI)	39.16
Average Volume (20 Days)	9,017,034

Short Selling Information

The latest short interest is 40.84 million, so 10.61% of the outstanding shares have been sold short.

Short Interest	40.84M
Short Previous Month	39.86M
Short % of Shares Out	10.61%
Short % of Float	11.75%
Short Ratio (days to cover)	4.13

Income Statement

In the last 12 months, Moderna had revenue of $5.08 billion and -$2.22 billion in losses. Loss per share was -$5.82.

Revenue	5.08B
Gross Profit	-1.40B
Operating Income	-2.69B
Pretax Income	-4.33B
Net Income	-2.22B
EBITDA	-2.36B
EBIT	-2.69B
Loss Per Share	-$5.82

Balance Sheet

The company has $6.87 billion in cash and $1.36 billion in debt, giving a net cash position of $7.85 billion or $20.39 per share.

Cash & Cash Equivalents	6.87B
Total Debt	1.36B
Net Cash	7.85B
Net Cash Per Share	$20.39
Equity (Book Value)	11.93B
Book Value Per Share	30.98
Working Capital	7.47B

Cash Flow

In the last 12 months, operating cash flow was -$3.21 billion and capital expenditures -$749.00 million, giving a free cash flow of -$3.96 billion.

Operating Cash Flow	-3.21B
Capital Expenditures	-749.00M
Free Cash Flow	-3.96B
FCF Per Share	-$10.28

Margins

Gross margin is -27.55%, with operating and profit margins of -53.00% and -43.77%.

Gross Margin	-27.55%
Operating Margin	-53.00%
Pretax Margin	-46.31%
Profit Margin	-43.77%
EBITDA Margin	-46.49%
EBIT Margin	-53.00%
FCF Margin	n/a

Dividends & Yields

Moderna does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.20%
Shareholder Yield	0.20%
Earnings Yield	-14.67%
FCF Yield	-26.10%

Analyst Forecast

The average price target for Moderna is $79.50, which is 101.83% higher than the current price. The consensus rating is "Hold".

Price Target	$79.50
Price Target Difference	101.83%
Analyst Consensus	Hold
Analyst Count	19
Revenue Growth Forecast (5Y)	8.02%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Moderna has an Altman Z-Score of 7.28 and a Piotroski F-Score of 1.

Altman Z-Score	7.28
Piotroski F-Score	1